Journal of Visualised Experiments (JoVE), 2013, 82, e50837

In vivo reprogramming of adult somatic cells to pluripotency by overexpression of Yamanaka factors

Açelya Yilmazer, Irene de Lázaro, Cyrill Bussy and Kostas Kostarelos

This study demonstrates the reprogramming of somatic cells towards pluripotency in vivo without the generation of teratomas. We used hydrodynamic tail vein injection of plasmid DNA encoding the Yamanka factors to induce the in vivo reprogramming of adult hepatocytes into cells of enhanced pluripotency. It can be concluded that reprogramming somatic cells in vivo may offer a potential approach to induce enhanced pluripotency rapidly, efficiently and safely compared to in vitro performed protocols and can be applied to different tissue types in the future.

Press releases on the article:

livescience
EurekAlert!
Newswise
Phys.org
Sciences Newsline
RedOrbit
ABC Salud
AZonano
Nigerian Guardian
Science Daily
Space Daily
Bio-Medicine
51agtc
Catalyst ScienceNews
Earth 2 Hub

In vivo reprogramming of adult somatic cells to pluripotency by overexpression of Yamanaka factors

In vivo reprogramming of adult somatic cells to pluripotency by overexpression of Yamanaka factors

RECENT PUBLICATIONSVIEW ALL

In vivo biomolecule corona and the transformation of a foe into an ally for nanomedicine

First-in-human controlled inhalation of thin graphene oxide nanosheets to study acute cardiorespiratory responses

Environmental and health impacts of graphene and other two-dimensional materials: a Graphene Flagship perspective

Clinical translation of graphene-based medical technology

Nanoporous graphene-based thin-film microelectrodes for in vivo high-resolution neural recording and stimulation

Engineering the glioblastoma microenvironment using TLR7/8 agonist-complexed graphene oxide nanosheets

Pulmonary toxicity of boron nitride nanomaterials is aspect ratio dependent

Delivery of graphene oxide nanosheets modulates glutamate release and normalizes amygdala synaptic plasticity to improve anxiety-related behavior

Graphene oxide nanosheets hamper glutamate mediated excitotoxicity and protect neuronal survival in an in vitro stroke model

Engineering of a graphene oxide-based two-dimensional platform for immune activation and modulation

PART OF

In vivo reprogramming of adult somatic cells to pluripotency by overexpression of Yamanaka factors

SHARE THIS

RECENT PUBLICATIONSVIEW ALL

In vivo biomolecule corona and the transformation of a foe into an ally for nanomedicine

First-in-human controlled inhalation of thin graphene oxide nanosheets to study acute cardiorespiratory responses

Environmental and health impacts of graphene and other two-dimensional materials: a Graphene Flagship perspective

Clinical translation of graphene-based medical technology

Nanoporous graphene-based thin-film microelectrodes for in vivo high-resolution neural recording and stimulation

Engineering the glioblastoma microenvironment using TLR7/8 agonist-complexed graphene oxide nanosheets

Pulmonary toxicity of boron nitride nanomaterials is aspect ratio dependent

Delivery of graphene oxide nanosheets modulates glutamate release and normalizes amygdala synaptic plasticity to improve anxiety-related behavior

Graphene oxide nanosheets hamper glutamate mediated excitotoxicity and protect neuronal survival in an in vitro stroke model

Engineering of a graphene oxide-based two-dimensional platform for immune activation and modulation

PART OF